Tauriga Sciences Inc. (OTCMKTS: TAUG) stock in the spotlight after recent news


New York-based Tauriga Sciences Inc. (OTCMKTS: TAUG) announced that its quarterly revenue for the fiscal 2nd quarter 2022 (period: July 1 – September 30, 2021) broke previous records. Tauriga is a diversified life sciences company whose quarterly net sales exceeded $ 125,000 for the first time ever. The gross turnover of the company was significantly higher.

The main product inventory was obtained by the company in the first week of August 2021. There has been no looking back since then, as customer feedback has been mostly positive. Their clientele has also grown steadily. We can say that the company is doing quite well.

Tauriga currently has six active revenue streams: retail sales, e-commerce sales, Amazon.com sales, salon sales, international transactions, “recurring” subscription sales.

With e-commerce now dominating, with the pandemic forcing people to flock to digital channels, it’s no surprise that the e-commerce section is the most profitable. The company’s highest-margin e-commerce business segment accounted for approximately 65% ​​of total quarterly net revenue.

The company is also making critical progress in its ongoing pharmaceutical development efforts. Shareholders will receive an additional update as soon as possible.

Market reaction:

On Friday, TAUG stock fell slightly to $ 0.0402 with over 303,000 shares, from its average volume of 622,000 shares. The stock traded in a range of $ 0.0360 to 0.0408 after opening the trade at $ 0.0405.

Leave A Reply

Your email address will not be published.